Generic anti-seizure drugs’ costs went down during the same time, study shows
But low profitability remains a barrier.
Few people with HDHPs proactively ask about or search for lower-cost care. This suggests opportunity for insurers, employers and health care providers to help.
Many adults haven’t talked to their doctors, pharmacists or nurses about drug interactions, a new national poll finds.